Abstract-Primary cultured human coronary myocytes (HCMs) derived from ischemic human hearts express an atypical voltage-gated tetrodotoxin (TTX)-sensitive sodium current (I Na ). The whole-cell patch-clamp technique was used to study the properties of I Na in HCMs. 
Key Words: vascular smooth muscle Ⅲ persistent Na ϩ current Ⅲ [Ca 2ϩ ] i Ⅲ Ca 2ϩ channel Ⅲ Na ϩ /Ca 2ϩ exchanger C a 2ϩ ions play a central role in the regulation of arterial smooth muscle tone. 1, 2 The changes in the cytosolic free calcium concentration ([Ca 2ϩ ] i ) mediate the effect of various vasoconstrictor and vasodilator agents, including hormones, neurotransmitters, and drugs that bind to specific receptors. Both direct mobilization of intracellular Ca 2ϩ and transmembrane Ca 2ϩ entry can activate contraction of smooth muscle cells. 2, 3 The relationship between smooth muscle membrane potential and arterial tone is quite steep. 3 Membrane depolarization results in activation of voltage-gated Ca 2ϩ channels, thereby leading to Ca 2ϩ influx. In contrast, membrane hyperpolarization through activation of potassium (K ϩ ) channels is an effective mechanism to inactivate Ca 2ϩ channels and thus dilate arteries. 3 Voltage-gated Na ϩ channels are generally responsible for the fast depolarizing phase of the action potential in most electrically excitable tissues. In response to moderate depolarization, these channels open for a few milliseconds and, thereby, generate a rapid and massive influx of Na ϩ ions promoting the large depolarization that gates other voltageactivated ion channels. Na ϩ channels are present in a wide variety of cells, including neurons and heart and skeletal myocytes. 4 -6 In contrast, Na ϩ channels have only recently been detected in arterial smooth muscle cells. [7] [8] [9] [10] [11] We have recently identified a tetrodotoxin (TTX)-sensitive I Na in primary cultured human coronary myocytes (HCMs) derived from end-stage failing hearts of transplanted patients with an ischemic cardiopathy. 10 This current exhibits quite unusual properties, including the presence of a sustained component resulting from very slow inactivation. The major aim of the present work was to investigate whether, and how, this current plays a role in the regulation of Ca 2ϩ homeostasis in HCMs.
Materials and Methods

Myocyte Isolation and Culture
Tissue samples were obtained from the left descending coronary artery of 6 male patients (age range, 44 to 58 years) undergoing heart transplantation. Those patients had end-stage heart failure (New York Heart Association, classes III and IV) caused by an ischemic disease. Cells were enzymatically isolated and grown in culture as described previously. 12, 13 Briefly, arteries were collected aseptically after cardiectomy, and myocytes were then dispersed in Hanks' solution containing 0.6 mg/mL collagenase (Worthington) and 1 mg/mL elastase (Boehringer Mannheim) for at least 50 minutes at 37°C. Next, the cells were centrifuged (100g, 7 minutes); resuspended in Ham's F-10 (Eurobio) supplemented with 10% human serum (Institut Jacques Boy SA), 2 mmol/L glutamine, and antibiotics (Eurobio); and plated (10 000 cells per mL) in 35-mm disposable Petri dishes (Falcon) that were placed at 37°C in an air/CO 2 incubator. The start medium was changed every day during the first week. Thereafter, the cells were transferred to maintenance medium (DMEM and Ham's F-10; 1:1 vol/vol; Eurobio) containing human serum (5%) and 5% FBS (Myoclone Super Plus; Life Technology, Cergy Pontoise, France), which was changed every 2 to 3 days. Confluence was obtained 15 to 20 days after plating.
Electrophysiological Recordings
The whole-cell patch-clamp technique 14 was performed at room temperature (20°C to 22°C). For whole-cell recordings, pipettes (borosilicate glass, Sutter) were filled with the following (in mmol/ L): CsCl 130, EGTA 10, HEPES 25, Mg-ATP 3, Na-GTP 0.5, glucose 10, succinic acid 5, and aspartic acid 5, with pH adjusted to 7.3 with CH 3 SO 3 H. The bathing solution contained the following (in mmol/L): NaCl 140, MgCl 2 2, CaCl 2 0.02, HEPES 10, 4-aminopyridine 5, and glucose 10, pH adjusted to 7.3 with CH 3 SO 3 H. Junction potential was zeroed before seal formation. Voltage errors resulting from the residual, uncompensated series resistance (Յ1 M⍀) were estimated to be Յ2 mV (I Na Ͻ2 nA). Leak and capacitive currents were subtracted using a 5-subpulse method. Sampling frequencies ranged from 0.16 to 2 kHz, and current signals were filtered at 3 to 5 kHz before digitization and storage. The holding potential (HP; Ϫ100 mV), test potentials, and rate of stimulation (0.1 Hz) were controlled with an IBM personal computer connected to the electrophysiological equipment (Axopatch 200A amplifier; Axon Instruments). Data acquisition and analysis were performed using the pCLAMP software (version 6.02). 16 Fura-2 calibration was performed as described previously. 17 The [Na ϩ ] i was measured in individual cells that had been loaded with the Na ϩ indicator benzofuran isophthalate (SBFI, 5 mol/L; Sigma). To load with SBFI-AM, cells were incubated in Locke buffer containing 5 mol/L SBFI-AM, 0.02% wt/vol Pluronic F-127 for 60 minutes at 37°C in a humidified air atmosphere. After loading, coverslips were rinsed with Locke buffer and mounted in a recording chamber. All recordings were made at room temperature (21°C to 23°C) using fast fluorescence photometry equipment previously described for [ . The control and test solutions were applied using a multiple capillary perfusion system (200 m inner diameter tubing, flow rate 100 L/min) placed to the proximity of each cell tested (Ͻ0.5 mm). Each capillary was fed by a reservoir 50 cm above the bath. After each application, the cells were washed with Locke buffer. Incubations (5 minutes) with inhibitory substances were carried out in a 500-L bath containing inhibitors diluted in Locke buffer.
Solutions for [
Analyses
The results were analyzed using the Student t test. Unless otherwise stated, all inhibitors used here showed a "significant" effect at PϽ0.01. The results are expressed as meanϮSEM.
Results
Window Current and Slow Inactivating Component
I Na in HCMs activates at voltages positive to Ϫ50 mV and peaks between Ϫ10 and 0 mV. 10 This is illustrated in Figure  1A . Another surprising feature is the presence of a slow inactivating current component with relatively large amplitude (up to 30% of total peak amplitude in some cells), which is totally blocked by 1 mol/L TTX ( Figure 1B ). The steady-state inactivation curve of I Na , determined by applying various conditioning potentials for 5 seconds before the test depolarization, shows that a significant fraction of I Na can still activate from depolarized membrane potentials ( Figure 1C ). The membrane potential at which 50% of the channels are still available for opening (V 0.5 ) is around Ϫ45 mV ( Figure  1D ). Furthermore, the overlap between the conductance and inactivation curves determines a "window" between Ϫ50 mV and Ϫ10 mV ( Figure 1D ), suggesting that a fraction of the Na ϩ channels are open and generate a steady-state Na ϩ influx in this range of potentials. At the minimum voltage required for activation (Ϫ40 mV), a substantial noninactivating Na ϩ influx was indeed observed ( Figure 1E ). However, a persistent component was also observed at all potentials of the I-V relationship ( Figure 1A) , ie, at potentials far higher than those determining the window current, indicating that a slow inactivating current is also generated by particular gating properties of the channels. Therefore, in addition to the overlap in the voltage-dependent activation/inactivation properties, the slow decay kinetics of I Na constitute an intrinsic mechanism to promote massive Na ϩ influx into the cells. Interestingly, the sustained component of I Na (I Na, sus ) was less sensitive to voltage-dependent inactivation than the peak current (I Na, peak ; Figure 1D ), implying that its amplitude also contributes to determine the amplitude of the steady-state window current (eg, at Ϫ30 mV; Figure 1D ).
Effect of Na ؉ Channel Agonists
To increase Na ϩ channel activity in non-voltage-clamped cells, HCMs were subjected to pharmacological agents known to be potent Na ϩ channel agonists. Although I Na in HCMs has particular properties, it can be blocked or enhanced by various specific agents and toxins 10 that bind on receptor sites of the vertebrate Na ϩ channel family. The water-soluble heterocyclic guanidine TTX binds to site 1 and block I Na in HCMs ( Figure 1B) . Toxin binding on the other receptor sites generally increases Na ϩ influx, although there are substantial mechanistic differences among the effects of various activators on I Na . This was also the case in HCMs for veratridine, which binds to site 2, and for toxin V from A sulcata, which binds to site 3. 4, 5, 19 The effect of veratridine is complex, as illustrated in Figure 2A . Veratridine (10 mol/L) decreased the peak amplitude of I Na by suppressing completely the fast inactivating component in all cells tested (nϭ12). However, it promoted at the same time the appearance of both a large sustained component during the test depolarization and a large, slowly deactivating tail Voltage-dependent steady-state availability (h ϱ ; Ⅺ, f ) and normalized conductance-voltage relationship (g Na /g Na, max ; E, F) of the I Na peak amplitude (I Na, peak ; f, F) and of the slowly inactivating (sustained) component of I Na (I Na, sus , which was measured after 200-ms depolarization; Ⅺ, E). g Na was calculated from the relation g Na ϭI Na /E m ϪE Na , with E Na considered as close to ϩ60 mV (E m is the membrane potential). The original data were taken from panel A. Curves were best fitted assuming a Boltzmann distribution using the equation g Na ϭg Na, max /{1ϩexp[(VϪV 0.5 )/k]}, where V 0.5 is the voltage at which g Na is half maximal and k the slope factor for the conductance increase. We determined that V 0.5 ϭϪ25 mV (kϭ4.9) for I Na, peak and V 0.5 ϭϪ26 mV (kϭ5.0) for I Na, sus . The h ϱ curves were determined from panel C. I Na was measured for each prepulse, normalized, and plotted as a function of the conditioning voltages. The fitted curves were obtained using the equation h ϱ ϭ1/(1ϩexp[(VϪV 0.5 )/k]), where V 0.5 is the voltage at which I Na is half inactivated and k the slope factor for voltage dependence. We determined that V 0.5 ϭϪ44 mV (kϭ7.7) for I Na, peak and V 0.5 ϭϪ35 mV (kϭ7.0) for I Na, sus . E, Example of sustained I Na recorded for a long depolarization at Ϫ40 mV (same cell as in panel A). Cell capacitance was 100 pF. current at repolarization. 10 The effect of toxin V from A sulcata (100 nmol/L) was different. This toxin increased consistently the peak amplitude of I Na (33Ϯ10%; nϭ6) and slowed significantly its decay, with no major effect on current deactivation ( Figure 2B ). However, the agonistic effect of both toxins was blocked by addition of 1 mol/L of TTX (Figure 2A and 2B) in all cells tested (nϭ4 for each). Veratridine and toxin V from A sulcata had no significant effect on the activation threshold of I Na in none of the four cells tested. In addition to these two natural toxins, we also used N-bromoacetamide, a chemical known to prolong the open time of Na ϩ channels and to slow the kinetics of macroscopic I Na . 4 In HCMs, we found that N-bromoacetamide (300 mol/L) had no significant effect on current amplitude (Ϫ5Ϯ8% decrease; nϭ4) but prevented the inactivation of I Na with no or only minor effect on the deactivating tail current. N-Bromoacetamide had no effect on the activation threshold of I Na (data not shown). Therefore, we expected that, despite clear mechanistic differences in their effects on Na ϩ channels gating in HCMs, veratridine, toxin V from A sulcata and N-bromoacetamide could be used to increase Na ϩ influx through drug-modified channels into non-voltage-clamped myocytes. We investigated whether the modulation of Na ϩ channel activity results in modulation of [Ca 2ϩ ] i in resting (nonvoltage-clamped) HCMs. To increase Na ϩ channel activity, the cells were subjected to veratridine (10 mol/L). ] i was greater in amplitude with veratridine and toxin V from A sulcata than with N-bromoacetamide. Biphasic responses (even oscillatory activity) were sometimes observed, possibly reflecting release of Ca 2ϩ from intracellular stores. In total, Ͼ80% of the cells responded to Na ϩ channel agonists. The rise in [Ca 2ϩ ] i was strictly dependent on the presence of external Na ϩ , consistent with our previous observation that I Na is abolished in Na ϩ -free conditions. 10 The increase in [Ca 2ϩ ] i induced by veratridine and toxin V from A sulcata was indeed abolished when extracellular Na ϩ was substituted with the nonpermeating N-methyl-D-glucamine ion (Figure 5Aa ). On average, veratridine, which increased [Ca 2ϩ ] i from 64Ϯ9 to 639Ϯ36 nmol/L (nϭ4) in the presence of external Na ϩ , had no effect after preincubation of the cells in the Na ϩ -free The effects of veratridine and toxin V from A sulcata were prevented in the presence of 1 mol/L TTX ( Figure 6A and 6B) and of 10 mol/L lidocaine ( Figure 6C ). The effects of agonists were recovered on washout of the antagonists (eg, see Figure 6A ). These experiments confirmed that the effects induced by the agonists reflect a genuine increase of Na ϩ channel activity. Furthermore, using the whole-cell technique (see Materials and Methods), we found that veratridine and toxin V from A sulcata were unable to promote any current in all of 6 cells with no detectable basal macroscopic I Na , suggesting that these agonists do not activate a silent Na ϩ channel (as has been reported for veratridine in rat aorta), 20 but rather modulate the activity of channels active at baseline. It was also unlikely that veratridine and toxin V cause any Ca 2ϩ influx, eg, by increasing the permeability of Na ϩ channels for Ca 2ϩ or by direct activation of Ca 2ϩ channels (I Na is decreased by external Ca 2ϩ ; S.R., J.F.Q., unpublished results, 1997).
Na
Involvement of Ca
2؉ Channels and Na ؉ /Ca 2؉ Exchanger
We assessed whether the rise in [Ca 2ϩ ] i induced by veratridine or toxin V from A sulcata involved depolarization-activated Ca 2ϩ channels. The rise in [Ca 2ϩ ] i observed after K ϩ depolarization was abolished by a saturating concentration of nicardipine (5 mol/L; data not shown), which blocks all of the L-type Ca 2ϩ current in these cells. 12 Veratridine, which (Figure 7Aa and 7Ab) . But, when extracellular Na ϩ was replaced by Li ϩ on an equimolar basis (Na ϩ -free medium), this residual component was abolished ( Figure  7Ba) . Similar results were observed in all cells tested (nϭ4). Because Li ϩ permeates through Na ϩ channels but is not taken by the Na ϩ /Ca 2ϩ exchanger, these data suggest that the dihydropyridine-insensitive Ca 2ϩ influx is provided by the exchanger working in reverse mode. Consistent with this observation, we found that, although Li ϩ and Na ϩ have similar permeating properties through the Na ϩ channels and, presumably, equivalent depolarizing effects, veratridine increased [Ca 2ϩ ] i from 34Ϯ7 to only 389Ϯ34 nmol/L (nϭ4) when Li ϩ was used as the permeating ion (in absence of Ca 2ϩ channel blocker) (Figure 7Bb) . Therefore, the rise was significantly lower than when Na ϩ was used as the permeating ion (611Ϯ44 nmol/L; nϭ12), confirming that the dihydropyridine-sensitive pathway is not the only route for Ca 2ϩ entry. This latter result was also consistent with the participation of the Na ϩ /Ca 2ϩ exchanger in the Ca 2ϩ influx activated after Na ϩ channel activation. The fact that veratridine induces a rise in [Na ϩ ] i suggests that the Na ϩ channels are active at baseline, given that this substance (and toxin V from A sulcata as well) would not work on closed channels. Indeed, the electrophysiological characterization is consistent with some Na ϩ channels being open in HCMs with membrane potentials between Ϫ50 and Ϫ10 mV ( Figure 1D ). We further assessed the existence of such a steady-state Na ϩ influx in resting (non-voltageclamped) SBFI-loaded cells. Brief applications of 1 mol/L TTX induced a decrease in the fluorescence ratio ( Figure 8A ) from 1.93Ϯ0.14 to 0.58Ϯ0.06, corresponding to a decrease in [Na ϩ ] i from 10.6Ϯ0.8 to 3.2Ϯ0.3 mmol/L (nϭ4). This decrease occurred within seconds after application of TTX and lasted as long as the blocker was applied. We next addressed the question of whether such a steady-state Na 
Na
Discussion
We recently reported the presence of voltage-activated I Na in cultured HMCs. 10 Because of particular voltage-and timedependent properties (compared with most types of I Na ), I Na here is likely to exert a unique type of regulation on the resting First, we demonstrated that an enhancement of Na ϩ channel activity using various agonists (N-bromoacetamide, vera- One is the sustained current predicted by the Hodgkin-Huxley analysis that occurs as a result of the voltage dependence of I Na activation and inactivation overlap. The other is the presence of slowly inactivating Na ϩ currents, which could be observed even at positive potentials, raising the possibility that these currents are generated by an unusual subtype of Na ϩ channels. However, whether the transient and the sustained component are related to one or two channels is not completely clear.
The fact that Na ϩ channels activators increase [Ca 2ϩ ] i as a result of the opening of voltage-gated Ca 2ϩ channels could be considered as relatively implicit, although this occurs at potentials relevant to vascular physiology. It could also be argued that the use of exogenous substances leads to unphysiological increases in [Na ϩ ] i . We actually used these agonists to identify clearly the mechanisms involved downstream. already open and may also help opening some others; (2) this leads to increased Na ϩ influx; and (iii) as channels become activated, the resulting depolarization recruits additional Na ϩ channels, which, ultimately, leads to activation of voltage-gated Ca 2ϩ channels. The prolonged activity of the HCM Na ϩ channels during sustained depolarization, their availability for opening from relatively depolarized membrane potentials, and the existence of a substantial window current at a wide range of potentials, are likely to confer a potential physiological role to these Na ϩ channels in the vascular myocytes. In a variety of neurons, such noninactivating I Na act physiologically to amplify synaptic potentials and set repetitive action potentials to enhance endogenous rhythmicity. [21] [22] [23] [24] [25] In cardiac cells, it is involved in the regulation of action potential duration and resting membrane potential. 26 -29 In HCMs, I Na may contribute to a tonic control of Ca 2ϩ channel activity, possibly counterbalancing membrane hyperpolarization through activation of K ϩ channels, and as a result of [Ca 2ϩ ] i . Interestingly, we detected a TTX-sensitive decrease in [Ca 2ϩ ] i in some cells with a high resting [Ca 2ϩ ] i , which may occur because of the overlap of the window currents generated by both Na ϩ channels and L-type Ca 2ϩ channels. Because I Ca starts to activate at ϷϪ30 mV, 12 this tonic control of Ca 2ϩ channel activity can probably be observed only in depolarized cells. The steady-state Na ϩ influx may therefore ensure a fine graded regulation of the steady-state Ca 2ϩ influx. It is certainly an effective mechanism to induce and maintain cell depolarization, to turn on Ca 2ϩ channel activity and promote sustained Ca 2ϩ influx and, in addition, to maintain elevated [Na ϩ ] i . Because I Na was observed in primary cultured cells, it is difficult to speculate on any physiological function in vivo at the moment. Direct extrapolation from in vitro observations to in vivo physiology must be considered with caution, specially because expression of I Na seems to be related to cell dedifferentiation. 10 Nevertheless, it is conceptually interesting to note that the repertoire of ion currents of HCMs is changing (eg, T-type Ca 2ϩ currents) during phenotypic modulation of the cells in vitro. 12 Interestingly, vascular smooth muscle cells in culture undergo many changes resembling those occurring in diseased vessels. Indeed, dedifferentiation and proliferative disorders play a major part in coronary artery diseases, including atherosclerosis, neointimal formation after endothelial injury, restenosis after angioplasty, and also hypertension. Therefore, the possibility that I Na is expressed under certain pathophysiological circumstances and helps regulate the basal arterial tonus, or other Ca 2ϩ -or Na ϩ -dependent function(s), is worth considering and will be explored in the near future.
